Research Antibodies & Reagents Market worth $36.62 billion by 2030, growing at a CAGR of 12.02% - Exclusive Report by 360iResearch

The "Research Antibodies & Reagents Market by Product (Antibodies, Reagent), Technology (Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence), Indication, Application, End User - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Research Antibodies & Reagents Market to grow from USD 16.54 billion in 2023 to USD 36.62 billion by 2030, at a CAGR of 12.02%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/research-antibodies-reagents?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Research antibodies are proteins produced by the body's immune system to respond to harmful substances or antigens, such as bacteria and viruses. Scientists synthetically produce these antibodies in laboratories for research purposes. Laboratory-produced research antibodies bind to specific antigens, thus marking them for identification, detection, or neutralization. These antibodies are integral in many research operations, including enzyme-linked immunosorbent assay (ELISA), immunohistochemistry, flow cytometry, western blotting, and immunofluorescence. Reagents in the context of scientific research refer to any substance that is utilized to induce a chemical reaction or to experiment if a reaction occurs. The wide array of research reagents entails enzymes, solvents, catalysts, buffers, and more, each with distinct uses and applications. Reagents play critical roles in molecular biology research, facilitating processes such as DNA replication, RNA transcription, protein synthesis, and cell lysis. The research antibodies and reagents market refers to the products, tools, and services researchers use in various fields such as healthcare, biotechnology, pharmaceuticals, and academic institutions to study diverse biological processes. Several factors contribute to the growth of the research antibodies and reagents market, including increasing research activities by pharmaceutical and biopharmaceutical companies and the rising popularity of proteomics and genomics research. The emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics supports this upward market growth. However, the growth of the research antibodies and reagents market is facing certain challenges, including the high cost of antibody development processes, and quality concerns, and a lack of reproducible results of research antibodies & reagents. On the other hand, increasing R&D in research antibodies & reagents and rising focus on discovering novel biomarkers present potential opportunities for the market to grow in the coming years.

Americas represents a highly developing landscape characterized by substantial investments in R&D activities by pharmaceutical and biotechnological companies and the presence of multiple research institutes. Additionally, the recent increase in patented scientific research augments the demand for research antibodies & reagents in the Americas. Significant governmental initiatives and investments to expand biotechnology research and development with advanced research equipment and tools are expected to foster the growth of the research antibodies & reagents market in Asia-Pacific. In May 2021, the Australian Government committed USD 206.4 million to a patent box tax incentive scheme to encourage investment in Australia's biotechnology and medical technology sectors. Asia's vast population, focus on investments in specialized clinical trial centers, and government support for clinical trials are significant factors in the region's reputation as a hub for successful clinical trials. The research antibodies & reagents market witnessed substantial growth in Europe, the Middle East, and African (EMEA) regions owing to the ongoing development of the life science industry. According to the United Kingdom Government, the country's healthy life science sector contributes more than USD 66 billion and 220,000 jobs annually to the UK economy.

Market Segmentation & Coverage:

This research report categorizes the Research Antibodies & Reagents Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Antibodies and Reagent. The Antibodies is further studied across Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Antibodies. The Reagent is further studied across Buffers, Enzymes, Fixatives, Media & Sera, Probes, Solvents, and Stains & Dyes. The Antibodies commanded largest market share of 60.97% in 2023, followed by Reagent.

Based on Technology, market is studied across Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, and Western Blotting. The Enzyme-linked Immunosorbent Assay commanded largest market share of 25.90% in 2023, followed by Immunohistochemistry.

Based on Indication, market is studied across Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem Cells. The Immunology commanded largest market share of 22.12% in 2023, followed by Stem Cells.

Based on Application, market is studied across Drug Development, Genomics, and Proteomics. The Genomics commanded largest market share of 56.32% in 2023, followed by Proteomics.

Based on End User, market is studied across Academic & Research Institutions, Contract Research Organizations, and Pharmaceutical & Biotechnology. The Contract Research Organizations commanded largest market share of 50.31% in 2023, followed by Pharmaceutical & Biotechnology.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.39% in 2023, followed by Americas.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/research-antibodies-reagents?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Research Antibodies & Reagents Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Research Antibodies & Reagents Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Research Antibodies & Reagents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc., Alpha Teknova, Inc., Atlas Antibodies AB, Avantor, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMérieux S.A., Cardinal Health, Inc., Cell Signaling Technology, Inc., Charles River Laboratories International, Inc., Danaher Corporation, Dovetail Genomics LLC, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GenScript Biotech Corporation, Honeywell International Inc., Illumia, Inc., ImmunoPrecise Antibodies Ltd., Leinco Technologies, Inc., LifeSpan BioSciences, Inc., LobaChemie Pvt. Ltd., Lonza Group Ltd., Merck KGaA, Omega Bio-tek, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Inc., Sino Biological, Inc., Thermo Fisher Scientific, Inc., Tokyo Chemical Industry Co., Ltd., and Tosoh Corporation.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Research Antibodies & Reagents Market, by Product
7. Research Antibodies & Reagents Market, by Technology
8. Research Antibodies & Reagents Market, by Indication
9. Research Antibodies & Reagents Market, by Application
10. Research Antibodies & Reagents Market, by End User
11. Americas Research Antibodies & Reagents Market
12. Asia-Pacific Research Antibodies & Reagents Market
13. Europe, Middle East & Africa Research Antibodies & Reagents Market
14. Competitive Landscape
15. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Research Antibodies & Reagents Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Research Antibodies & Reagents Market?
3. What is the competitive strategic window for opportunities in the Research Antibodies & Reagents Market?
4. What are the technology trends and regulatory frameworks in the Research Antibodies & Reagents Market?
5. What is the market share of the leading vendors in the Research Antibodies & Reagents Market?
6. What modes and strategic moves are considered suitable for entering the Research Antibodies & Reagents Market?

Read More @ https://www.360iresearch.com/library/intelligence/research-antibodies-reagents?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.